OSMO-LogoOSMO-LogoOSMO-LogoOSMO-Logo
  • Home
  • Corporate Members
  • Agenda
    • Agenda May 13
    • Agenda May 22
  • Previous Conferences
    • October 8th 2020
    • October 24th 2020
  • Contact us
  • Home
  • About us
  • Our services
  • Our clients
  • Contact

Please don’t hesitate to email executivedirector@osmoconference.org or complete the contact form.

Contact Us
© 2021 Oregon Society of Medical Oncology (OSMO) Conference. All Rights Reserved.
      This browser is no longer recommended for use by Microsoft. To optimize your security and experience on OSMOCONFERENCE website, we suggest using Google Chrome, Firefox or Microsoft Edge.
      epizyme

      Company Overview

      Epizyme, Inc. is a fully integrated biopharmaceutical company committed to rewriting treatment for cancer and other serious diseases through transformative epigenetic medicines. In addition to a robust research and discovery pipeline, Epizyme has one commercial oncology product and is exploring the treatment potential of this therapy in investigational clinical trials focused on other conditions. By focusing on the genetic drivers of disease, Epizyme works to match new medicines with the patients who need them. For more information, visit www.epizyme.com.